Business StandardCenter·
Mankind Pharma soars 11% in 2 days on strong Q2 earnings; brokerages upbeat
Mankind Pharma share price: Going ahead, improving domestic volumes, rising chronic contribution and sustained export momentum are expected to support growth, say analysts.
Read at Business Standard →




